Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia

Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia

(2013) V. Gagne et al.   CLINICAL CANCER RESEARCH

Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

(2013) Lynda M. Vrooman et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia

(2012) J. J. Yang et al.   BLOOD

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia

(2011) J. Rousseau et al.   BLOOD

Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity

(2011) Romain Guilhaumou et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

(2011) Ching-Hon Pui et al.   JOURNAL OF CLINICAL ONCOLOGY

An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics

(2011) S J Wolf et al.   PHARMACOGENOMICS JOURNAL

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases

(2010) Romain Guilhaumou et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia

(2010) Akinbode Egbelakin et al.   PEDIATRIC BLOOD & CANCER

The actin-capping protein CapG localizes to microtubule-dependent organelles during the cell cycle

(2009) Thomas Hubert et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia

(2009) M. Ansari et al.   BLOOD

MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents

(2009) Erica L. Woodahl et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

(2009) L B Silverman et al.   LEUKEMIA

Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia

(2009) A. Hartman et al.   LEUKEMIA RESEARCH